Targeting N-Myristoylation Through NMT2 Prevents Cardiac Hypertrophy and Heart Failure.

Tomita, Yusuke; Anzai, Fumiya; Misaka, Tomofumi; Ogawara, Ryo; Ichimura, Shohei; Wada, Kento; Kimishima, Yusuke; Yokokawa, Tetsuro; Ishida, Takafumi; Takeishi, Yasuchika

Targeting N-Myristoylation Through NMT2 Prevents Cardiac Hypertrophy and Heart Failure.

Tomita, Yusuke; Anzai, Fumiya; Misaka, Tomofumi; Ogawara, Ryo; Ichimura, Shohei; Wada, Kento; Kimishima, Yusuke; Yokokawa, Tetsuro; Ishida, Takafumi; Takeishi, Yasuchika.

Afiliação

Tomita Y; Department of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.
Anzai F; Department of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.
Misaka T; Department of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.
Ogawara R; Department of Community Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.
Ichimura S; Department of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.
Wada K; Department of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.
Kimishima Y; Department of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.
Yokokawa T; Department of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.
Ishida T; Department of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.
Takeishi Y; Department of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.